• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征(SARS)相关冠状病毒感染过程中的抗体反应和病毒血症。

Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection.

作者信息

Chen Weijun, Xu Zuyuan, Mu Jingsong, Yang Ling, Gan Haixue, Mu Feng, Fan Baoxing, He Bo, Huang Shengyong, You Bo, Yang Yongkui, Tang Xiangjun, Qiu Ling, Qiu Yan, Wen Jie, Fang Jianqiu, Wang Jian

机构信息

Beijing Genomics Institute, Chinese Academy of Sciences, Beijing 101300, China 2Beijing BGI-GBI Biotech Co. Ltd, Beijing 101300, China 3Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, China 4Beijing 302 Hospital, Beijing 100039, China 5Beijing 301 Hospital, Beijing 100853, China 6Beijing Union Hospital, Beijing 100730, China 7Beijing Red Cross Blood Center, Beijing 100088, China.

出版信息

J Med Microbiol. 2004 May;53(Pt 5):435-438. doi: 10.1099/jmm.0.45561-0.

DOI:10.1099/jmm.0.45561-0
PMID:15096554
Abstract

To understand the time-course of viraemia and antibody responses to severe acute respiratory syndrome-associated coronavirus (SARS-CoV), RT-PCR and ELISA were used to assay 376 blood samples from 135 SARS patients at various stages of the illness, including samples from patients who were in their early convalescent phase. The results showed that IgM antibodies decreased and became undetectable 11 weeks into the recovery phase. IgG antibodies, however, remained detectable for a period beyond 11 weeks and were found in 100 % of patients in the early convalescent phase. SARS-CoV viraemia mainly appeared 1 week after the onset of illness and then decreased over a period of 1 month, becoming undetectable in the blood samples of the convalescent patients. At the peak of viraemia, viral RNA was detectable in 75 % of blood samples from patients who were clinically diagnosed with SARS 1 or 2 weeks before the test.

摘要

为了解严重急性呼吸综合征相关冠状病毒(SARS-CoV)病毒血症和抗体反应的时间进程,采用逆转录聚合酶链反应(RT-PCR)和酶联免疫吸附测定(ELISA)对135例处于疾病不同阶段的SARS患者的376份血样进行检测,包括处于恢复期早期患者的样本。结果显示,IgM抗体在恢复期第11周时下降并变得无法检测到。然而,IgG抗体在11周后仍可检测到,且在恢复期早期100%的患者中均可发现。SARS-CoV病毒血症主要在发病1周后出现,然后在1个月内下降,在恢复期患者的血样中变得无法检测到。在病毒血症高峰期,在检测前1或2周临床诊断为SARS的患者75%的血样中可检测到病毒RNA。

相似文献

1
Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection.严重急性呼吸综合征(SARS)相关冠状病毒感染过程中的抗体反应和病毒血症。
J Med Microbiol. 2004 May;53(Pt 5):435-438. doi: 10.1099/jmm.0.45561-0.
2
Serology of severe acute respiratory syndrome: implications for surveillance and outcome.严重急性呼吸综合征的血清学:对监测及预后的意义
J Infect Dis. 2004 Apr 1;189(7):1158-63. doi: 10.1086/380397. Epub 2004 Mar 16.
3
Antibody responses against SARS-coronavirus and its nucleocaspid in SARS patients.SARS患者针对严重急性呼吸综合征冠状病毒及其核衣壳的抗体反应。
J Clin Virol. 2004 Sep;31(1):66-8. doi: 10.1016/j.jcv.2004.05.006.
4
Evaluation by indirect immunofluorescent assay and enzyme linked immunosorbent assay of the dynamic changes of serum antibody responses against severe acute respiratory syndrome coronavirus.通过间接免疫荧光测定法和酶联免疫吸附测定法评估针对严重急性呼吸综合征冠状病毒的血清抗体反应的动态变化。
Chin Med J (Engl). 2005 Mar 20;118(6):446-50.
5
Kinetics of severe acute respiratory syndrome (SARS) coronavirus-specific antibodies in 271 laboratory-confirmed cases of SARS.271例实验室确诊的严重急性呼吸综合征(SARS)病例中SARS冠状病毒特异性抗体的动力学研究
Clin Diagn Lab Immunol. 2004 Jul;11(4):792-4. doi: 10.1128/CDLI.11.4.792-794.2004.
6
Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus.严重急性呼吸综合征(SARS)冠状病毒所致肺炎患者针对SARS冠状病毒核衣壳蛋白的免疫球蛋白G(IgG)、IgM和IgA抗体的纵向变化情况
Clin Diagn Lab Immunol. 2004 Jul;11(4):665-8. doi: 10.1128/CDLI.11.4.665-668.2004.
7
[Serological analysis of SARS Coronavirus in children diagnosed clinically as severe acute respiratory syndrome cases during SARS epidemic in Beijing].[北京非典疫情期间临床诊断为严重急性呼吸综合征病例的儿童中SARS冠状病毒的血清学分析]
Zhonghua Er Ke Za Zhi. 2006 Apr;44(4):262-6.
8
Longitudinal analysis of Severe Acute Respiratory Syndrome (SARS) coronavirus-specific antibody in SARS patients.严重急性呼吸综合征(SARS)患者中SARS冠状病毒特异性抗体的纵向分析。
Clin Diagn Lab Immunol. 2005 Dec;12(12):1455-7. doi: 10.1128/CDLI.12.12.1455-1457.2005.
9
Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase.SARS患者康复期尿液和粪便中持续排出活的SARS-CoV。
Eur J Clin Microbiol Infect Dis. 2005 Mar;24(3):165-71. doi: 10.1007/s10096-005-1299-5.
10
Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital.台湾一家医院医护人员使用恢复期血浆治疗严重急性呼吸综合征的经验。
J Antimicrob Chemother. 2005 Nov;56(5):919-22. doi: 10.1093/jac/dki346. Epub 2005 Sep 23.

引用本文的文献

1
Recent advances in immunoassay technologies for the detection of human coronavirus infections.免疫分析技术在人类冠状病毒感染检测中的最新进展。
Front Cell Infect Microbiol. 2023 Jan 4;12:1040248. doi: 10.3389/fcimb.2022.1040248. eCollection 2022.
2
Plant Molecular Pharming and Plant-Derived Compounds towards Generation of Vaccines and Therapeutics against Coronaviruses.植物分子制药与植物衍生化合物用于研发抗冠状病毒疫苗和治疗药物
Vaccines (Basel). 2022 Oct 26;10(11):1805. doi: 10.3390/vaccines10111805.
3
Evaluation of two RT-PCR techniques for SARS-CoV-2 RNA detection in serum for microbiological diagnosis.
评价两种血清中 SARS-CoV-2 RNA 检测的 RT-PCR 技术在微生物诊断中的应用。
J Virol Methods. 2022 Feb;300:114411. doi: 10.1016/j.jviromet.2021.114411. Epub 2021 Dec 12.
4
Data analytics to evaluate the impact of infectious disease on economy: Case study of COVID-19 pandemic.评估传染病对经济影响的数据分析:以新冠疫情为例
Patterns (N Y). 2021 Aug 13;2(8):100315. doi: 10.1016/j.patter.2021.100315. Epub 2021 Jul 27.
5
Impaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease Severity.入住重症监护病房的新冠肺炎患者外周血单个核细胞细胞毒性反应受损:预测疾病严重程度的生物标志物
Front Immunol. 2021 May 26;12:665329. doi: 10.3389/fimmu.2021.665329. eCollection 2021.
6
The impact of viremia on organ failure, biomarkers and mortality in a Swedish cohort of critically ill COVID-19 patients.在瑞典危重症 COVID-19 患者队列中,病毒血症对器官衰竭、生物标志物和死亡率的影响。
Sci Rep. 2021 Mar 30;11(1):7163. doi: 10.1038/s41598-021-86500-y.
7
A case of COVID-19 pneumonia successfully treated with favipiravir (Avigan) in which serum SARS-CoV-2 RNA detected by LAMP method was clinically useful.芦可替尼(捷恪卫)联合环磷酰胺治疗骨髓纤维化的安全性和有效性
J Infect Chemother. 2021 Feb;27(2):379-383. doi: 10.1016/j.jiac.2020.10.011. Epub 2020 Oct 10.
8
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.一项在 18-59 岁健康成年人中进行的新型冠状病毒灭活疫苗的安全性、耐受性和免疫原性的随机、双盲、安慰剂对照、1/2 期临床试验。
Lancet Infect Dis. 2021 Feb;21(2):181-192. doi: 10.1016/S1473-3099(20)30843-4. Epub 2020 Nov 17.
9
Antibody kinetics and serologic profiles of SARS-CoV-2 infection using two serologic assays.使用两种血清学检测方法分析 SARS-CoV-2 感染的抗体动力学和血清学特征。
PLoS One. 2020 Oct 22;15(10):e0240395. doi: 10.1371/journal.pone.0240395. eCollection 2020.
10
Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的无症状和有症状患者的抗体血清转化
Clin Transl Immunology. 2020 Sep 26;9(9):e1182. doi: 10.1002/cti2.1182. eCollection 2020.